Peculiarities of the distribution and expression dynamics of apoptosis marker Bax in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy with the usage of nitric oxide precursor

Authors

  • V. V. Golotyuk

DOI:

https://doi.org/10.14739/2310-1237.2015.2.50817

Keywords:

Rectal Neoplasms, Apoptosis, Radiotherapy, Therapeutical Pathomorphosis, Drug Therapy, Nitrogen Oxides

Abstract

The aim of research – to determine the proapoptotic Bax protein expression peculiarities in the intact intestine and tumor of patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy (NHRT), including the polyradiomodification using Ftorafur and Tivortine.

Methods and results. Bax expression was determined by immunohistochemistry in biopsy and surgical material before and after NHRT in 21 patients with adenocarcinoma of the rectum stage II-III. It was established that under the influence of NHRT Bax expression level in the intact rectum increased slightly. However, expression of Bax in residual tumor parenchyma loci increased sharply compared with that before treatment, especially after polyradiomodification, thus correlating with the degree of therapeutic pathomorphosis.

Conclusion. This indicates the importance of the apoptosis as a mechanism of NHRT antineoplastic action, as well as the feasibility of the polyradiomodification with the usage of nitric oxide precursor.

References

Cartron, P. F., Juin, P., Oliver, L., Meflah, K., & Vallette, F.M. (2003) Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment. Expert Rev Anticancer Ther, 3(4), 563–570. doi:10.1586/14737140.3.4.563.

Hector, S., & Prehn, J. H. (2009). Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochim Biophys Acta, 1795(2), 117–129. doi: 10.1016/j.bbcan.2008.12.002.

Pryczynicz, A., Gryko, M., Niewiarowska, K., Cepowicz, D., Ustymowicz, M., Kemona, A., & Guzińska-Ustymowicz, K. (2014). Bax protein may influence the invasion of colorectal cancer. World Journal of Gastroenterology, 20(5), 1305–1310. doi: 10.3748/wjg.v20.i5.1305.

Fil`chenkov, А. А. (2005). Vizualizaciya i ocenka apoptoza, vyzvannogo protivoopukholevoj terapiej: klinicheskie perspektivy [Visualization and evaluation of apoptosis induced by anti-tumor therapy: clinical perspectives]. Oncology, 13(4), 266–277. [in Ukrainian].

Brunelle, J.K., & Letai, A. (2009). Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci, 122, 437–441. doi: 10.1242/jcs.031682.

Wörnle, M., Schmid, H., Merkle, M., & Banas, B. (2004). Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol, 5, 8. doi: 10.1186/1471-2369-5-8.

De Ridder, M., Van Esch, G., Engels, B., Verovski, V., & Storme, G. (2008). Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. Bull Cancer, 95(3), 282–291. doi: 10.1684/bdc.2008.0592.

Yasuda, H. (2008). Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer. Nitric Oxide, 19(2), 205–216. doi: 10.1016/j.niox.2008.04.026.

Singh, S., Gupta, A. K. (2011). Mini review nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol, 67(6), 1211–1224. doi: 10.1007/s00280-011-1654-4.

Mojic, M., Mijatovic, S., Maksimovic-Ivanic, D., Miljkovic, D., Stosic-Grujicic, S., Stankovic, M., et al. (2012). Therapeutic potential of nitric oxide-modified drugs in colon cancer cells. Mol Pharmacol, 82(4), 700–710.

Downloads

How to Cite

1.
Golotyuk VV. Peculiarities of the distribution and expression dynamics of apoptosis marker Bax in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy with the usage of nitric oxide precursor. Pathologia [Internet]. 2015Oct.8 [cited 2024Nov.8];(2). Available from: http://pat.zsmu.edu.ua/article/view/50817

Issue

No. 2 (2015)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).